Report period | 2019 | 2020 | 2021 | 2022 | 2023 | Q2 24 |
---|---|---|---|---|---|---|
End date of the reporting period | ||||||
Capitalization, ₽ | ||||||
Capitalization, $ | ||||||
Enterprise Value | ||||||
Book Value | ||||||
Shareholders Book Value | ||||||
Current liabilities | ||||||
Noncurrent liabilities | ||||||
Total liabilities | ||||||
Debt | ||||||
Cash and cash equivalents | ||||||
Net debt | ||||||
Assets | ||||||
Total ordinary shares | ||||||
Ordinary share price |
Ticker | Name | Type | Nominal value | ISIN | Price |
---|---|---|---|---|---|
LIFE:RM | Pharmsynthesis | Common share | RUB 5 | RU000A0JR514 | RUB 3.995 |
Company name | Pharmsynthesis |
---|---|
Tags | #pharmacy, #innovations of the russia |
Sector | Health Care / Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals / Pharmaceuticals |
Business address | Rossiyskaya Federaciya, Leningradskaya oblast, Vsevolozhskiy rayon |
Mailing address | 188663 Rossiyskaya Federaciya, Leningradskaya oblast, Vsevolozhskiy rayon, gorodskoy poselok Kuzmolovskiy, stanciya Kapitolovo, 134 str. 1 |
CEO | Prilezhaev Efim Aleksandrovich |
Phone | 329-80-80 |
Website | pharmsynthez.com |
Information disclosure | e-disclosure.ru |